NEW YORK, June 10 (GenomeWeb News) - Shares in Illumina were down 5.53 percent, or $.67, at $11.45 in mid-afternoon trading after an investment bank downgraded the company's stock.
The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.
